Could a drug-discovery robot be named on a patent as an “inventor”? Usually to obtain a patent, the invention must not be obvious to a person of skill in the relevant field. But it seems conceivable that an algorithm could identify drug candidates that are entirely non-obvious to human experts… Amy Nick tackles AI inventorship in addition to other legal, regulatory and commercial issues pertaining to AI in pharma. Elsewhere, you’ll find articles on the rise of single use, economic incentives in clinical trials, as well as kickstarting Alzheimer’s R&D.


All the best, James Strachan, Deputy Editor

A Matter of Trust
09/07/2020 | Maryam Mahdi
Can we trust the integrity of clinical trials?
Does AI Dream of Electric Patents?
09/09/2020 | Amy Nick
When it comes to using AI in drug development, companies need to consider how they create and protect their intellectual property.
Charting the Rise of Single Use
08/20/2020 | Stephanie Sutton
Single-use systems have come a long way. We look at experience with the technology so far.
Rejuvenating Alzheimer’s R&D
08/24/2020 | Maryam Mahdi
How can companies be encouraged to develop treatments for the growing number of patients living with CNS disorders?
Find New Uses for Old Drugs

On September 29, The Medicine Maker and Vectura will explore the opportunities in repurposing and repositioning existing therapies for new uses. Find out more

Smart Shipping Solutions For Cell Therapy Logistics

Join The Medicine Maker and Cytiva on September 10 for a webinar on overcoming cell therapy logistics without the hazards of liquid nitrogen. Find out more

White Papers
Early Stage Product Development Using Laser Diffraction Analysis

Particle size and size distribution are often important parameters in defining product performance. Read More.

In vitro bioequivalence studies for oral solid dose products

The Morphologi® ID can be used to compare material and chemical properties of Active Pharmaceutical Ingredients (APIs) in a drug product using Morphologically-Directed Raman Spectroscopy (MDRS®). Read More.

Product Profile
Bioavailability and Development Toolkit

With global development and manufacturing sites, Catalent combines its formulation and bioavailability enhancement experience, along with delivery technologies, to support new product launches. Read more

Special Promotions
Embedding your drug strategy within a solid foundation for success

This white paper explores the broad set of trends influencing pharmaceutical development and manufacturing strategy, and how these drivers are influencing new business models with outsourced partners. Find out more

A dedicated cell + gene therapy newsletter from The Medicine Maker team

Join 1,000s of peers from across the pharmaceutical, investment, and regulatory sectors for expert insight, analysis and words of wisdom on everything cell + gene therapy. Subscribe Now

The Innovation Awards 2020, Nominations now OPEN!

Nominations are now open for The Medicine Maker 2020 Innovation Awards. Coming to our December issue of The Medicine Maker, The Innovation Awards will showcase the top technologies to have been released throughout 2020. Nominations will close on November 3, 2020. Good Luck!

Must-See Events Worldwide

We work with event organizers from all around the world to help bring the pharma industry together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and and stay up-to-date with the latest developments.

Find out more